The American College of Cardiology (ACC) will host the annual Advancing the Cardiovascular Care of the Oncology Patient course on April 14-16, 2023, in Washington, DC. The course is intended for all members of the interprofessional care team—including cardiologists, oncologists, pharmacists and nurses—and aims to equip the global cardio-oncology community with the tools they need to improve patient care.
Ana Barac, MD, PhD, FACC, and Bonnie Ky, MD, MSCE, FACC, will serve as co-directors for the course, which will be available both in-person and online. The course will bring together clinicians and researchers from across the globe to share emerging strategies and best practices for managing the cardiovascular health of cancer patients.
“I am proud to say that the ACC course has set the standards for cardio-oncology education, including joint presentations of oncologists and cardiologists modeling real-life patient care and collaboration across CV and oncology teams,” Barac said. “This year, our theme is collaboration and innovation through science and for our patients. I am very excited about the first-ever joint sessions with the American Society of Clinical Oncology and the American Society of Hematology that are a testament of the commitment of our professional societies to collaborate and address the gaps that exist across specialties.”
Can’t Miss Sessions:
- Pharmacology Essentials for Cardio-Oncology Practice
- How to Build and Grow a Cardio-Oncology Program
- The Global Burden and Significance of Cancer and Cardiovascular Disease
- Cardiovascular Disparities in Cancer Patients and Survivors: Strategies to Implement Inclusive, Equitable Care
- Physical Activity Interventions in Our Cancer Patients and Survivors: Why, When, and How?
Posters
The following abstract titles are a selection of posters being presented during the conference. All ACC Advancing the Cardiovascular Care of the Oncology Patients posters and abstracts are embargoed until Friday, April 14, 2023, at 9 a.m. ET.
- Racial Disparities in Cardiotoxicity Following Cancer Treatment: A Systematic Review and Meta-Analysis
- Assessment of Detectable Atherosclerosis on Computed Tomography Imaging in Breast Cancer Patients Entering Treatment
- Prevalence of Statin Use and Dyslipidemia Screening for Secondary Cardiovascular Prevention in Patients with Cancer
- SGLT2 Inhibitors are Associated with a Lower Risk of Malnutrition and Cachexia in Patients with Heart Failure Receiving Anthracycline Treatment
